Risk factors for gestational diabetes mellitus in Sudanese pregnant women

Similar documents
Incidence of gestational diabetes mellitus in pregnant women

4/15/2013. Maribeth Inturrisi RN MS CNS CDE Perinatal Diabetes Educator

How To Know If You Have Microalbuminuria

Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference

Gestational diabetes mellitus (GDM) is defined

Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus

Population health management: Gestational diabetes mellitus programme at HMC Women s Hospital

This guideline is the NICE Diabetes in Pregnancy guideline with additions where appropriate to explain implementation within UHL.

Jill Malcolm, Karen Moir

How To Determine The Prevalence Of Microalbuminuria

Gestational Diabetes Mellitus AADE Practice Synopsis Issued December 19, 2013

RESULTS. Group I: consists of 30 healthy pregnant women with uncomplicated pregnancy. Group II consists of 30 pregnant women with mild preeclampsia.

Scientific Impact Paper No. 23. January Diagnosis and Treatment of Gestational Diabetes

Exceptional People. Exceptional Care. Antenatal Appointment Schedule for Normal Healthy Women with Singleton Pregnancies

St Lucia Diabetes and Hypertension Screening and Disease Management Programs

Gestational Diabetes Screening and Treatment Guideline

Women and Diabetes- The Primary Care Perspective. Sara G. Tariq, M.D., F.A.C.P. Associate Prof, Internal Medicine

SWISS SOCIETY OF NEONATOLOGY. Umbilical cord complications in two subsequent pregnancies

Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.

Insulin Resistance and PCOS: A not uncommon reproductive disorder

1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME

Published Quarterly Mangalore, South India ISSN Volume 4, Issue 1; January-March 2005

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)

Diabetes Complications

Gestational Diabetes in UNRWA health clinics in Gaza Strip: Impact of Educational Program.

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY*

Diabetes in pregnancy: its impact on Australian women and their babies

Diagnosis, classification and prevention of diabetes

Overview of Diabetes Management. By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health

Family History and Diabetes. Practical Genomics for the Public Health Professional

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities

Control of hypertension in Nigerians with Diabetes Mellitus: A report of the Ibadan Diabetic / Kidney Disease Study Group.

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU

The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C:

Diabetes and Obesity in Children. Janie Berquist, RN, BSN, MPH, CDE Children s Mercy Hospitals and Clinics Kansas City, MO

Take a moment Confer with your neighbour And try to solve the following word picture puzzle slides.

Gestational Diabetes Mellitus (GDM)

Screening, Diagnosis and Management of Gestational Diabetes in New Zealand. A clinical practice guideline

Kansas Behavioral Health Risk Bulletin

Diabetes mellitus. Lecture Outline

Long-term outcome in offspring of women with diabetes in pregnancy - what is the role of intrauterine hyperglycemia?

INSULIN REQUIREMENT IN DIABETIC PATIENTS WITH CHRONIC RENAL FAILURE DUE TO DIABETIC NEPHROPATHY (DN)

Diabetes Prevention in Latinos

Sponsor. Novartis Generic Drug Name. Vildagliptin. Therapeutic Area of Trial. Type 2 diabetes. Approved Indication. Investigational.

Sedentarity and Exercise in the Canadian Population. Angelo Tremblay Division of kinesiology

A Comparison of Spot Urine Protein-Creatinine Ratio With 24-hour Urine Protein Excretion in Women With Preeclampsia

Prediction of neonatal hypoglycemia using cord blood C-peptide and cord HbA1c in infant Of diabetic mother

Scottish Diabetes Survey Scottish Diabetes Survey Monitoring Group

Improving cardiometabolic health in Major Mental Illness

Improving drug prescription in elderly diabetic patients. FRANCESC FORMIGA Hospital Universitari de Bellvitge

Do You Know the Health Risks of Being Overweight?

Excellence in Care: Diabetes and Pregnancy

DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE

Mortality Assessment Technology: A New Tool for Life Insurance Underwriting

Prevalence of microalbuminuria among sudanese type 2 diabetic patients at elmusbah center at ombadda - omdurman

What women can do to optimise their health during pregnancy and that of their baby Claire Roberts

SAMPLE. UK Obstetric Surveillance System. Management of Pregnancy following Laparoscopic Adjustable Gastric Band Surgery.

Type 1 Diabetes ( Juvenile Diabetes)

Summary ID# Clinical Study Summary: Study F3Z-JE-PV06

Guidelines for the management of hypertension in patients with diabetes mellitus

California Diabetes and Pregnancy Program (CDAPP) Sweet Success

THE STUDY OF NEWLY DISCOVERED CASES OF DIABETES MELLITUS IN BIHOR COUNTY

The Influence of Infant Health on Adult Chronic Disease

Institute of Applied Health Sciences. University of Aberdeen DATABASE REVIEW. Grampian University. Hospitals NHS Trust GRAMPIAN DIABETES

Treatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections.

The Impact of WIC on Birth Outcomes. Patrick M Catalano MD. Case Western Reserve University Cleveland, Ohio U.S.A.

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Tuberculosis And Diabetes. Dr. hanan abuelrus Prof.of internal medicine Assiut University

How To Test For Microalbuminuria

Deakin Research Online

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT

Markham Stouffville Hospital

Correspondence to: Rima B Shah (rima_1223@yahoo.co.in) DOI: /ijmsph Received Date: Accepted Date:

K. SUNANDA BAI,** M.D., D.G.O.

Scottish Diabetes Survey Scottish Diabetes Survey Monitoring Group

Assessment of Fetal Growth

Proposed Data Collection Submitted for Public Comment and. AGENCY: Centers for Disease Control and Prevention (CDC),

DIABETES MELLITUS. By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria

The Prevalence and Determinants of Undiagnosed and Diagnosed Type 2 Diabetes in Middle-Aged Irish Adults

ETIOLOGIC CLASSIFICATION. Type I diabetes Type II diabetes

Comparative evaluation of two treatment regimens, diet versus insulin, in gestational diabetes mellitus

Packages of antenatal care for low-risk pregnancy

OET: Listening Part A: Influenza

Antiretroviral treatment is Associated with increased Arterial Stiffness in Sub- Saharan African HIV-1 Infected Patients: A cross- Sectional Study

Resistance exercise decreases the need for insulin in overweight women with gestational diabetes mellitus

CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications

Obesity in the United States Workforce. Findings from the National Health and Nutrition Examination Surveys (NHANES) III and

AUSTRALIA AND NEW ZEALAND FACTSHEET

Sample Service Specifications

The Post-Bariatric Patient during Pregnancy Impact on Diabetes and Hypertension. Eyal Sheiner M.D, PhD

This guideline is the NICE Diabetes in Pregnancy guideline with additions where appropriate to explain implementation within UHL.

Study Design and Statistical Analysis

Statins and Risk for Diabetes Mellitus. Background

Understanding diabetes Do the recent trials help?

A STUDY OF MAGNESIUM SUPPLEMENTATION ON GLYCEMIC CONTROL IN PATIENTS OF TYPE-2 DIABETES MELLITUS

Objectives. What Is Diabetes? 1/26/2015. Carbs & Meds & Meters, Oh My!: Diabetes in Pregnancy

DIABETES YOUR GUIDE TO

Delayed effects from past high-level exposures in a fishing community: Type 2 diabetes in septuagenarians

Transcription:

International Journal of Medicine and Biomedical Research www.ijmbr.com Michael Joanna Publications Original Article Risk factors for gestational diabetes mellitus in Sudanese pregnant women Mardi T.G 1, Lutfi M.F 2 * 1 Department of Physiology, Faculty of Medicine and Health Sciences, Omdurman Islamic University, Sudan. 2 Department of Physiology, Faculty of Medicine and Health Sciences, Alneelain University, Sudan. * Corresponding author: moh12312@yahoo.co.uk ABSTRACT Background: The prevalence of gestational diabetes mellitus (GDM) in Sudan is less compared with international reports. Whether there is concomitant difference in the risk factors for GDM among Sudanese women is uncertain. Aim: This study investigated the common risk factors for GDM among Sudanese pregnant women. Materials and Method: The study involved a control group of 60 apparently healthy pregnant women matched with a test group of 60 pregnant women with GDM. Data were obtained through a questionnaire, proper examination, including anthropometric measurements, and laboratory evaluation for glycaemic control. Results: The age (mean (M) ± standard deviation (SD) = 32.8±7.4 years) and body mass index (BMI) (M±SD = 27.9±4.9 Kg/m2) were significantly higher in pregnant ladies with GDM compared with the control group (M±SD = 29.7±6.0 years, 25.1±3.1 Kg/m2 respectively) (P < 0.02 for both). There were significant associations between presence of GDM and age 30 years (relative risk (RR) = 1.28, P = 0.016), BMI 25 Kg/m2 (RR = 1.48, P = 0.001), family history of diabetes mellitus (DM) (RR = 1.8, P = 0.002), glucosuria (RR = 2.39, P = 0.000), proteinuria (RR = 1.98, P = 0.008). In contrast, parity and urinary tract infections failed to demonstrate significant associations with GDM. Conclusion: The strongest predictor of GDM in Sudanese women is glucosuria, followed by proteinuria, family history of DM, BMI 25 Kg/m2 and age 30 years in a descending pattern. Key words: Diabetes mellitus, gestation, risk factors, Sudan INTRODUCTION Gestational diabetes mellitus (GDM) is a universal risk factor for maternal and neonatal morbidity and mortality. [1] Low gestational age, neonatal macrosomia, hypoglycemia, respiratory distress syndrome are frequent complications of GDM and explain the increased rate of admission among neonates following delivery of their diabetic mothers. [2,3] Therefore, early detection, proper diagnosis and adequate management of GDM are crucial clinical tools to diminish its potential complications. [4] An effective way for earlier detection for GDM is screening mothers at higher risk to develop this disease. Screening is usually based on the presence or absence of certain documented risk factors for GDM. The well-known screening guidelines for GDM are those recommended by the British National Institute for Health and Clinical Excellence (NICE) [5] and the American Diabetes Association (ADA). [1,6] According to these guidelines, the most common risk factors for GDM are advanced maternal age, higher body 79

mass index (BMI), family history of diabetes mellitus, past history of GDM or a baby with one of the known complication of GDM. It is worth to mention that some previous studies confirmed other risk factors for GDM, however, they were not considered in these guidelines e.g. spontaneous abortion, [7] glucosuria, [8] proteinuria, [9] high blood pressure [10] and vulvovaginal candidiasis. [7] In Sudan, studies investigating GDM are scarce. [11-13] The only available report in the literature regarding risk factors for GDM in Sudanese pregnant ladies was conducted by Khattab and his colleagues in 2007. [11] The prevalence rate of GDM estimated by Khattab et al. was 2% and is relatively lower compared with international reports in which prevalence rate reached up to 7%. [14] This variation in the prevalence rate between Sudanese and international reports remains to be explored by further researches; but it also suggests concomitant variation in the risk factors for GDM among Sudanese pregnant women. According to Khattab et al study, parity was an important risk factor for impaired glucose tolerance; however, no additional risk factors were reported. This study aimed to investigate the common risk factors for GDM among Sudanese pregnant women including those not considered in NICE and ADA guidelines. MATERIALS AND METHODS The study received ethical clearance from the Gezira University. The authorities of the chosen hospitals were informed and their permissions were taken accordingly. The study involved two groups: a control group of 60 apparently healthy pregnant women matched with a test group of 60 pregnant women with GDM. The sample size was determined by the following formula: N = t 2 pq/d 2 Where; N = required sampling size, t= the confidence level, taken as 1.96, P = anticipated population, taken as 0.02 according to Khattab et al., [11] q = 1-p = 0.98 and d = absolute precision required, taken as 0.05. Accordingly the required sample will be: 1.96 2 (0.02)(0.98)/(0.5) 2 = 30 pregnant women. The sample size was further increased to 60 pregnant ladies to safeguard against possible contingencies like blood sample damage and recording errors. Women were recruited mainly from obstetric outpatient clinics in the Khartoum state-sudan. The age of both groups ranged between 18-50 years. Following history taking and clinical examination, blood samples were taken to assess patients glycaemic control. Mean arterial blood pressure (MABP) for each subject was determined by the formula: MABP = diastolic blood pressure + [(systolic blood pressure diastolic blood pressure)/3]. Body mass index (BMI) was calculated using the formula: BMI (Kg/m 2 ) = Weight (Kg) / (Height (m)) 2. Statistical analysis Statistical analysis was performed using the SPSS (SPSS for windows version 19) and Microsoft Office Excel (Microsoft Office Excel for windows; 2007). Normal distribution of studied variables was examined using Kolmogorov-Smirnova and Shapiro-Wilk tests. Unpaired T-test and Mann-Whitney U test were used to assess significant difference in the means of the studied variables in the different groups. Chi-square test and relative risk were used to assess the association between GDM and the possible risk factors. P < 0.05 was considered significant. RESULTS The age (mean (M) ± standard deviation (SD) = 32.8±7.4 years) and body mass index (BMI) (M±SD = 27.9±4.9 Kg/m 2 ) were significantly higher in pregnant women with GDM compared with the control group (M±SD = 29.7±6.0 years, 25.1±3.1 Kg/m 2 respectively) (P < 0.02 for both). Regarding the other studied variables, the means, standard deviations and the significance of the difference of the means between the test and the control groups (P) are given in table 1, figure 2 and 3. Random blood glucose concentrations and blood pressures were significantly higher in pregnant women with proteinuria compared with those without proteinuria (P 0.003). There were significant associations between presence of GDM and age 30 years (relative risk (RR) = 1.28, P = 0.016), BMI 25 Kg/m 2 (RR = 1.48, P = 0.001), family history of diabetes mellitus (DM) (RR = 1.8, P = 0.002), glucosuria (RR = 2.39, P = 0.000), proteinuria (RR = 1.98, P = 0.008). In contrast, parity and urinary tract infections failed to demonstrate significant associations with GDM (table 2). 80

DISCUSSION The main outcome of the current study is the strong association between GDM and increased ages, systolic hypertension, higher BMI, family history of diabetes mellitus, glucosuria and proteinuria. In contrast, parity and urinary tract infections failed to demonstrate significant associations with GDM. According to the relative risks, the strongest predictor of GDM was presence of glucosuria, followed by proteinuria, family history of diabetes mellitus, BMI 25 Kg/m 2 and Age 30 years in a descending pattern. These findings were comparable with previous international reports. [1,2,6] For example, a recent large epidemiological survey conducted in China to determine the risk factors of GDM revealed significant association between GDM and advanced maternal age, pre-pregnancy obesity and family history of diabetes. [7] However, a history of recurrent vulvovaginal candidiasis and spontaneous abortion were new risk factors in that survey. A comparable study was conducted in Iranian women and gave analogous risk factors, namely like age >30 years, family history of diabetes, obesity and glycosuria. [8] Table 1: characteristics of the test and control groups Pregnant Pregnant women with women with no GDM GDM (N = 60) (N = 60) M±SD M±SD P Value Age (years) 29.7±6.0 32.8±7.4 0.013* Weight (Kg) 73.0±9.8 79.5±11.6 0.000* Height (Cm) 170.6±5.7 169.5±7.7 0.616 BMI (Kg/m 2 ) 25.1±3.1 27.9±4.9 0.000* Fasting Blood Glucose(mg/dL) 86.9±16.5 114.4±40.3 0.000* Random Blood Glucose (mg/dl) 102.2±14.6 171.1±55.0 0.000* 2Hours after meal Blood Glucose (mg/dl) 151.3±27.3 189.6±40.2 0.000* Diastolic Blood Pressure (mmhg) 79.2±7.4 83.1±14.8 0.134 Systolic Blood Pressure (mmhg) 121.4±8.1 125.2±13.4 0.020* Mean Blood Pressure (mmhg) 93.3±6.9 97.1±12.8 0.073 * Significant difference of the means Table 2: Associations between GDM and anticipated risk factors Risk Factor Relative Risk Pearson χ 2 P Value Age ( 30 years old Vs <30 years old) 1.28 5.76 0.016* BMI ( 25 Kg/m 2 Vs <25 Kg/m 2 ) 1.48 10.28 0.001* Parity (multipara Vs primagravidae) 1.31 1.82 0.178 History of Diabetes in the Family 1.80 9.64 0.002* Glucosuria 2.36-0.000* Proteinuria 1.98-0.008* Urinary tract infection 1.24 1.32 0.251 * Significant associations Cannot tolerate Chi-Square test, Fisher's exact test was used instead 81

Figure 1: Means and standard deviations of studied groups ages Figure-2: Means and standard deviations of studied groups anthropometric measurements Figure 3: Means and standard deviations of studied groups blood pressures 82

Literature regarding glucosuria and proteinuria as risk factors for GDM is inadequate. The relatively high glomerular filtration rate and low renal threshold for glucose explain glucosuria among pregnant ladies. Glycosuria is likely in about 50% of pregnant women [15] while GDM affects only about 7% of all pregnancies worldwide. [14] The sensitivity of glucosuria for diagnosing GDM is only 8.2% according to a recent study. [16] Notwithstanding, according to [8, 17] the findings of this study and others, glucosuria is proven to be a significant risk factor for GDM. A good explanation for the low prevalence and intermittent nature of glucosuria among patients with GDM was given by a novel study conducted by Coolen and Verhaeghe. [16] Their results showed that pure urine responders (any glycosuria but glucose <130 mg/dl) were younger and had a lower body weight and BMI when compared with plasma responders (no glycosuria but plasma glucose 140 mg/dl). This finding suggests that glucosuria is more likely in those with smaller plasma distribution volume. Accordingly, patients with increased BMI are at higher risk to develop GDM. However, they are less likely to have glucosuria. [16] The proteinuria of late pregnancy is exaggerated in women with diabetes, which also increases the risk of preeclampsia. This fact is further supported by the results of the current study which demonstrated that pregnant women with proteinuria had poor glycaemic control and higher systolic blood pressure compared with those with no proteinuria. Most of the data published on GDM covers the risks of preeclampsia [10] which in turn explain the strong association between proteinuria and GDM in this study. [9] It has been postulated that GDM may be the first manifestation in those who will later develop diabetes mellitus (DM) and therefore they share common abnormalities like high blood pressure. [18] This is supported by Clark et al. results which confirmed that numerous of the recognized metabolic components of the syndrome of insulin resistance (syndrome X) are predictive of GDM. [19] Alternatively, against the postulation that GDM is the first stage of DM is failure of previous researches to show direct association between measures of insulin resistance and high blood pressure. [20] Montoro et al compare the degree of insulin resistance in women with GDM who do and do not develop preeclampsia. [20] Results revealed no significant differences between the two groups regarding measures of the oral glucose tolerance tests, insulin sensitivity index, free fatty acid in either the third trimester or 15 months postpartum. These findings suggest that women who developed preeclampsia were not more insulin resistant when compared with those who remained non-preeclamptic. In conclusion, it is clear that risk factors for GDM in Sudanese women are comparable with international reports. The strongest predictor of GDM was found to be glucosuria, followed by proteinuria, family history of diabetes mellitus, BMI 25 Kg/m 2 and Age 30 years in a descending pattern. On the contrary, parity and UTI failed to demonstrate significant associations with GDM. ACKNOWLEDGMENT During this work, we have collaborated with many colleagues, for whom we have great regards, and we wish to extend our warmest thanks to Dr. Elsadig M, Dr. Ramaze F. Elhakeem and Khatir B. REFERENCES 1. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 2003;26:S103-5. 2. Svare JA, Hansen BB, Mølsted-Pedersen L. Perinatal complications in women with gestational diabetes mellitus. Acta Obstet Gynecol Scand 2001;80:899-904. 3. Setji T, Brown A, Feinglos M. Gestational Diabetes Mellitus. Clinical Diabetes 2005;23:17-24 4. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477-86. 5. The Guideline Development Group. Management of diabetes from preconception to the postnatal period: summary of NICE guidance. BMJ 2008; 336: 714 717. 6. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2008; 31: S55 S60. 7. Yang H, Wei Y, Gao X, Xu X, Fan L, He J, Hu Y, Liu X, Chen X, Yang Z, Zhang C. Risk factors for gestational diabetes mellitus in Chinese women: a prospective study of 16,286 pregnant women in China. Diabet Med 2009;26:1099-104. 8. Keshavarz M, Cheung NW, Babaee GR, Moghadam HK, Ajami ME, Shariati M. Gestational diabetes in Iran: incidence, risk factors and 83

pregnancy outcomes. Diabetes Res Clin Pract 2005;69:279-86. 9. Powe CE, Thadhani R. Diabetes and the kidney in pregnancy. Semin Nephrol 2011;31:59-69. 10. Beucher G, Viaris de Lesegno B, Dreyfus M. Maternal outcome of gestational diabetes mellitus. Diabetes Metab 2010;36:522-37. 11. Khattab A, Satti G, Shalayel M, Ahmed S. Prevalence of gestational diabetes mellitus and impaired glucose tolerance in pregnant Sudanese women in the third trimester. Sud Med Monitor J 2007;2:59-61 12. Abdelgadir M, Elbagir M, Eltom A, Eltom M, Berne C. Factors affecting perinatal morbidity and mortality in pregnancies complicated by diabetes mellitus in Sudan. Diabetes Res Clin Pract 2003;60:41-7. 13. Ahmed SA, Shalayel MH. Role of cortisol in the deterioration of glucose tolerance in Sudanese pregnant women. East Afr Med J 1999;76:465-7. 14. Perkins JM, Dunn JP, Jagasia SM. Perspectives in gestational diabetes mellitus: a review of screening, diagnosis, and treatment. Clin Diabetes 2007;25:57 62. 15. Alto WA. No need for glycosuria/proteinuria screen in pregnant women. J Fam Pract 2005;54:978-83. 16. Coolen JC, Verhaeghe J. Physiology and clinical value of glycosuria after a glucose challenge during pregnancy. Eur J Obstet Gynecol Reprod Biol 2010;150:132-6. 17. Schytte T, Jørgensen LG, Brandslund I, Petersen PH, Andersen B. The clinical impact of screening for gestational diabetes. Clin Chem Lab Med 2004;42:1036-42. 18. Szymanska M, Bomba-Opon DA, Wielgos M. Blood pressure and lipid changes in gestational diabetes mellitus. Neuro Endocrinol Lett 2008;29:328-33. 19. Clark CM Jr, Qiu C, Amerman B, Porter B, Fineberg N, Aldasouqi S, Golichowski A. Gestational diabetes: should it be added to the syndrome of insulin resistance? Diabetes Care 1997;20:867-71. 20. Montoro MN, Kjos SL, Chandler M, Peters RK, Xiang AH, Buchanan TA. Insulin resistance and preeclampsia in gestational diabetes mellitus. Diabetes Care 2005;28:1995-2000. doi: http://dx.doi.org/10.14194/ijmbr.1113 How to cite this article: Mardi T.G, Lutfi M.F. Risk factors for gestational diabetes mellitus in Sudanese pregnant women. Int J Med Biomed Res 2012;1(1):79-84 Conflict of Interest: None declared 84